1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Cancer Market Trends
  5. > Analytical Tool - Lymphoma

Analytical Tool - Lymphoma

  • March 2014
  • -
  • Bioseeker

Executive Summary

"Analytical Tool: Lymphoma" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in lymphoma R&D and business development. It is also a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future. The product as well, lays the framework of current treatment strategies and their progress. This tool provides you with an immense amount of information structured and analyzed to assist you in your work. It is designed to assist you in finding the right partners, optimizing your licensing deals, wisely choosing which projects give you the best competitive advantage, and assuring you that your decisions have been based on the most accurate, validated and precise facts available.

Included in this advantageous package are two products already appreciated by many of our customers - A Decision Support Tool for Optimizing The Lymphoma Pipeline: From Research and Development to Market and Lymphoma Drug Pipeline Update 2014*.

The Package Includes
- A progress analysis on current and emerging drugs
- Information on most companies active in lymphoma R&D
- Information on key industry related lymphoma projects
- Data from most important clinical trials
- Information on early developmental stage projects
- Possibility of performing advanced searches suited to your individual needs

This Tool will Assist You in:
- Tracking cutting edge companies, therapies and new technologies
- Rapid identification of partners & competitors
- Laying down a comprehensive framework for further analysis of the field
- Producing presentations surrounding the development of lymphoma therapeutics
- Identifying emerging lymphoma products & key areas of pharmaceutical R&D

*This software application is a searchable database reflects the most recent advances in the field of lymphoma drug development, in order to help you perform your own analysis, go back to the source data for in-depth information, and present the research and development in tables and graphs suited for your own specific purposes. A significant advantage with BioSeeker's software applications is that they provide you with well-structured information. Each pipeline drug/project has been carefully defined and classified in categories and subcategories. The main categories include therapy type, effect, mechanism of action (molecular target), indication, stage of development etc. These categories are further organized and classified in sub-categories. In comparison with other available databases, BioSeeker’s software applications give better overview, specific search capabilities and great dynamic reports.

Table Of Contents

Analytical Tool - Lymphoma

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell Division Protein Kinase 9 or Serine/Threonine Protein Kinase PITALR or CDK9 or EC 2.7.11.22 or EC 2.7.11.23) - Pipeli

Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell Division Protein Kinase 9 or Serine/Threonine Protein Kinase PITALR or CDK9 or EC 2.7.11.22 or EC 2.7.11.23) - Pipeli

  • $ 3 500
  • Industry report
  • July 2016
  • by Global Markets Direct

Cyclin Dependent Kinase 9 (Tat Associated Kinase Complex Catalytic Subunit or C 2K or Cell Division Cycle 2 Like Protein Kinase 4 or Cell Division Protein Kinase 9 or Serine/Threonine Protein Kinase PITALR ...

Histone Deacetylase 1 (EC 3.5.1.98) - Pipeline Review, H1 2016

Histone Deacetylase 1 (EC 3.5.1.98) - Pipeline Review, H1 2016

  • $ 3 500
  • Industry report
  • June 2016
  • by Global Markets Direct

Histone Deacetylase 1 (EC 3.5.1.98) - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Histone Deacetylase 1 (EC 3.5.1.98) - Pipeline Review, H1 2016’, provides in depth analysis on Histone ...

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Alpha Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Alpha or Phosphoinositide 3 Kinase Catalytic Alpha Polypeptide or Serine/Threonine Protein Kinase PIK3

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Alpha Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Alpha or Phosphoinositide 3 Kinase Catalytic Alpha Polypeptide or Serine/Threonine Protein Kinase PIK3

  • $ 3 500
  • Industry report
  • July 2016
  • by Global Markets Direct

Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Alpha Isoform (Phosphatidylinositol 4,5 Bisphosphate 3 Kinase 110 kDa Catalytic Subunit Alpha or Phosphoinositide 3 Kinase Catalytic Alpha ...


Download Unlimited Documents from Trusted Public Sources

Brain Cancer Statistics in Australia

  • September 2016
    102 pages
  • Brain Cancer  

    Therapy  

  • Australia  

View report >

Cancer Statistics in Switzerland

  • September 2016
    5 pages
  • Cancer  

  • Switzerland  

    United States  

View report >

Breast Cancer Statistics and Pathology Statistics in the US

  • September 2016
    85 pages
  • Breast Cancer  

    Pathology  

  • United States  

View report >

Related Market Segments :

Lymphoma

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.